Nalaganje...

CDK9 is a prognostic marker and therapeutic target in pancreatic cancer

Despite recent advances in diagnosis and therapy, prognosis of pancreatic cancer still remains very poor. Besides valid prognostic markers, novel therapeutic approaches are urgently needed. The family of cyclin-dependent kinases comprises 20 kinases which contribute to malignancy by promoting prolif...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Anna-Laura Kretz, Monika Schaum, Julia Richter, Ella F Kitzig, Christine C Engler, Frank Leithäuser, Doris Henne-Bruns, Uwe Knippschild, Johannes Lemke
Format: Artigo
Jezik:Inglês
Izdano: SAGE Publishing 2017-02-01
Serija:Tumor Biology
Online dostop:https://doi.org/10.1177/1010428317694304
Oznake: Označite
Brez oznak, prvi označite!